Extendicare Inc.
EXETF
$9.08
$0.0020.02%
| Weiss Ratings | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | A | |||
| Rating Factors | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.77 | |||
| Price History | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 11.95% | |||
| 30-Day Total Return | 29.57% | |||
| 60-Day Total Return | 24.09% | |||
| 90-Day Total Return | 39.10% | |||
| Year to Date Total Return | 26.18% | |||
| 1-Year Total Return | 90.02% | |||
| 2-Year Total Return | 118.41% | |||
| 3-Year Total Return | 84.68% | |||
| 5-Year Total Return | 131.17% | |||
| 52-Week High % Change | -0.22% | |||
| 52-Week Low % Change | 81.60% | |||
| Price | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.10 | |||
| 52-Week Low Price | $5.00 | |||
| 52-Week Low Price (Date) | Mar 08, 2024 | |||
| 52-Week High Price (Date) | Mar 05, 2025 | |||
| Valuation | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 753.53M | |||
| Enterprise Value | 872.33M | |||
| Price/Earnings (TTM) | 14.51 | |||
| Earnings Per Share (TTM) | 0.63 | |||
| Earnings Per Share Growth | 142.00% | |||
| Price/Earnings To Growth | 0.10 | |||
| Price/Sales (TTM) | 0.80 | |||
| Price/Book (Q) | 8.77 | |||
| Enterprise Value/Revenue (TTM) | 0.82 | |||
| Price | $9.08 | |||
| Enterprise Value/EBITDA (TTM) | 8.60 | |||
| Enterprise Value/EBIT | 10.71 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 94.84M | |||
| Dividend Yield | 3.80% | |||
| Div. Per Share (Most Recent) | $0.03 | |||
| Dividend Per Share (TTM) | $0.35 | |||
| Payout Ratio (TTM) | 53.30% | |||
| Dividend Per Share (Most Recent) | $0.03 | |||
| Company Info | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 470 4000 | |||
| Address | 3000 Steeles Avenue East Markham, ON L3R 4T9 | |||
| Website | www.extendicare.com | |||
| Country | Canada | |||
| Year Founded | 1968 | |||
| Profitability | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.61% | |||
| Profit Margin | 5.12% | |||
| Management Effectiveness | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.08% | |||
| Return on Equity | 71.66% | |||
| Income Statement | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.07B | |||
| Total Revenue (TTM) | 1.07B | |||
| Revenue Per Share | $11.28 | |||
| Gross Profit (TTM) | 147.34M | |||
| EBITDA (TTM) | 101.47M | |||
| EBIT (TTM) | 81.44M | |||
| Net Income (TTM) | 54.82M | |||
| Net Income Avl. to Common (TTM) | 54.82M | |||
| Total Revenue Growth (Q YOY) | 8.68% | |||
| Earnings Growth (Q YOY) | 124.69% | |||
| EPS Diluted (TTM) | 0.63 | |||
| EPS Diluted Growth (Q YOY) | 311.34% | |||
| Balance Sheet | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 84.68M | |||
| Cash Per Share (Q) | $0.89 | |||
| Total Current Assets (Q) | 169.37M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 86.43M | |||
| Current Ratio (Q) | 0.832 | |||
| Book Value Per Share (Q) | $1.04 | |||
| Total Assets (Q) | 500.26M | |||
| Total Current Liabilities (Q) | 203.55M | |||
| Total Debt (Q) | 203.67M | |||
| Total Liabilities (Q) | 413.83M | |||
| Total Common Equity (Q) | 86.43M | |||
| Cash Flow | EXETF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -6.64M | |||
| Cash from Financing (TTM) | -63.73M | |||
| Net Change in Cash (TTM) | 34.84M | |||
| Levered Free Cash Flow (TTM) | 71.07M | |||
| Cash from Operations (TTM) | 105.21M | |||
